Molecular response to therapy appears to correlate with event-free survival in patients with early polycythemia vera (PV), according to a new analysis. The findings were published in a research letter in the journal HemaSphere.1 While clonal expansion of JAK2V617F-mutated hematopoietic […]
Molecular Response to Therapy Linked With Event-Free Survival in PV Read More »
Patients with large B-cell lymphoma (LBCL) who relapse soon after CD19-directed chimeric antigen receptor (CAR) T-cell therapy are particularly unlikely to respond to bispecific antibody therapy, a new report in Blood Advances found.1 Though CAR T-cell therapies have made a
Early Relapse After CAR T-Cell Therapy Linked With Poor BsAb Outcomes in LBCL Read More »
Patients with myasthenia gravis (MG) who have light sensitivity tend to have lower quality-of-life scores, a new report has found. The study, based on 92 patients and 75 healthy controls, suggests that light sensitivity may be a more important symptom
Light Sensitivity Linked With Lower Quality of Life in Myasthenia Gravis Read More »
A new dual-modal, non-invasive detection technique could make it easier—and faster—to differentiate between melanoma skin cancer and benign lesions. The combination of optical coherence tomography (OCT) and Raman spectroscopy achieved 96.9% accuracy in differentiating melanoma and benign lesions when paired
Novel, Non-Invasive Skin Cancer Detection Method Shows Promise Read More »
Patients with pulmonary fibrosis (PF) and pulmonary hypertension (PH) have superior transplant-free survival outcomes if they receive pulmonary vasodilator therapy in combination with antifibrotic therapy, a new report published in Therapeutic Advances in Respiratory Disease found. The study offers some
Dual Therapy Appears to Benefit Patients With Pulmonary Fibrosis, Pulmonary Hypertension Read More »
A new scoring system could help more accurately characterize a patient’s risk of developing atrial fibrillation (AF) while taking Bruton tyrosine kinase inhibitors (BTKis) for chronic lymphocytic leukemia (CLL), according to a study published in the European Journal of Haematology.1
Novel AI-Based Score Could Pinpoint AF Risk in Patients With CLL on BTKis Read More »
Teenagers taking lebrikizumab (Ebgylss; Lilly) for atopic dermatitis appeared to experience improvements in anxiety and depression symptoms as a result of their treatment, a new study found.1 The results align with a meta-analysis that suggests the therapy enhances disease control
People with rheumatoid arthritis have a significantly higher risk of avoidable hospitalizations in the years after their diagnosis, a new study shows. The risk is particularly high for hospitalizations related to heart failure and pulmonary edema, according to the study,
Rheumatoid Arthritis Linked With Heightened Risk of Avoidable Hospitalizations Read More »
Clinical trials for idiopathic pulmonary fibrosis could benefit from improved patient engagement to include diverse perspectives and inclusive practices. Image credit: DC Studio – stock.adobe.com Current methods of conducting trials related to idiopathic pulmonary fibrosis (IPF) therapies do not do
IPF Trial Practices Often Exclude Certain Patients, Perspectives Read More »
Racial and ethnic minority populations continue to be underrepresented in randomized controlled trials (RCTs) of metabolic dysfunction–associated steatohepatitis (MASH), although inclusion of female and Hispanic/Latino populations has increased over time, a meta-analysis published in the journal Liver International found.1 The
MASH Clinical Trials Historically Underrepresent Certain Groups Read More »
